HENDERSON MICHAEL THOMAS sold APGE

February 11, 2026 · Form 4 insider transaction

HENDERSON MICHAEL THOMAS sold 7,551 shares of Apogee Therapeutics, Inc. at $63.73 per share, a transaction worth $481.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
7,551
Price
$63.73
Total value
$481.2K
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 11, 2026
Filing dateFebruary 13, 2026
Shares owned after1,173,942
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025.; The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.33 to $64.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

View the original Form 4 on SEC EDGAR